A Girl or Boy, You Pick
By Aaron Zitner,
The Los Angeles Times
| 07. 23. 2002
She had the name picked out since high school: Logann Rae,
taken from a soap opera. She had two dolls waiting in a closet,
both saved since childhood. Tanya had always dreamed of having
a daughter, and of the intimate bond that would grow as they
picked out dresses together, styled their hair and painted their
fingernails. But Tanya's first child was a son. Then came another.
When an ultrasound showed that her third child was also a boy,
she struggled to hide her tears from the nurse.
And that is why this year she drove 400 miles to a doctor's
office in Westwood. Using methods common in fertility clinics,
doctors mixed Tanya's eggs with her husband's sperm to create
five embryos in a laboratory dish. Then, using a new technique,
they examined the embryos to determine which had the DNA to
become boys, and which were programmed to be girls.
The three male embryos were frozen, their fate to be decided
later. The two female embryos were transferred to Tanya's womb
in an attempt to create the daughter she...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...